ask="N/A"
ask_size="N/A"
average_daily_volume="74324"
bid="14.25"
bid_size="400"
book_value="-91.82"
change="+1.33"
change_from_200_day_moving_average="4.82"
change_from_50_day_moving_average="3.40"
change_from_52_week_high="-0.54"
change_From_52_week_low="7.26"
change_in_percent="+7.40%"
close="19.31"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-41.42"
ebitda="-20.24M"
eps_estimate_current_year="-2.50"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.93"
ex_dividend_date="N/A"
float_shares="8856000"
high="19.85"
high_52_weeks="19.85"
last_trade_date="2/9/2017"
last_trade_price="19.31"
last_trade_size="2794"
last_trade_time="4:00pm"
low="17.87"
low_52_weeks="12.05"
market_capitalization="435.36M"
moving_average_200_day="14.49"
moving_average_50_day="15.91"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.50"
open="17.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+33.27%"
percent_change_from_50_day_moving_average="+21.35%"
percent_change_from_52_week_high="-2.72%"
percent_change_from_52_week_low="+60.23%"
previous_close="17.98"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="70.51"
revenue="5.75M"
shares_outstanding="22546000"
short_ratio="3.28"
stock_exchange="NGM"
symbol="RARX"
volume="47512"
weeks_range_52="12.05 - 19.85"
